B Lymphoblastic Leukemia Lymphoma Bcr Abl1 Like Cn324053
A B-cell leukemia that acts like Philadelphia chromosome-positive disease but lacks the typical fusion. Seen in children and young adults, it needs aggressive treatment with targeted agents.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Vision loss
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Frequent infections
(hematologic)Pallor
(hematologic)Weight loss
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Tyrosine Kinase Inhibitor-Based Therapy
BCR-ABL1-like leukemia often responds to tyrosine kinase inhibitors such as dasatinib or ponatinib combined with chemotherapy, targeting activated kinase pathways driving malignancy.
Multi-agent Chemotherapy Regimen
Standard ALL chemotherapy protocols adapted for high-risk B-ALL including CNS prophylaxis with intrathecal methotrexate combined with systemic agents.
Additional treatment options
CAR-T Cell Therapy
Autologous T cells engineered to target CD19 antigen on B-ALL cells, providing targeted immunotherapy for relapsed or refractory disease.
procedureNutritional Support Therapy
Aggressive nutritional intervention including parenteral or enteral nutrition to prevent treatment-related malnutrition common during intensive chemotherapy phases.
dietaryMolecular Profiling and MRD Assessment
Comprehensive genomic profiling to identify specific kinase alterations and regular minimal residual disease monitoring to guide therapy intensification or de-intensification.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma Bcr Abl1 Like Cn324053?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hoffbrand AV, Campana D, Lee JW. BCR-ABL1-like B-ALL: NCCN Clinical Practice Guidelines in Oncology. Blood Adv. 2023.
Roberts KG, Mullighan CG, Hunger SP. BCR-ABL1-like acute lymphoblastic leukemia: molecular and clinical correlates. J Clin Oncol. 2022.
Den Boer ML, Stam RW, Pieters R. Dasatinib in BCR-ABL1-like B-ALL (COG AALL1131): a phase III clinical trial. Lancet Haematol. 2021.
Moorman AV, Harrison CJ, Fielding PA. Prognostic significance of BCR-ABL1-like signature in childhood B-ALL: systematic review and meta-analysis. Haematologica. 2020.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma Bcr Abl1 Like Cn324053. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy